Researchers at NYU Langone Health developed a new drug that targets mutant HER2 cancer proteins without harming healthy cells ...

For some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between ...

Scientists at NYU have created a drug that targets cancer-causing HER2 mutations without harming healthy cells. This new ...

A new study describes the development of a biologic, a drug derived from natural biological systems, that targets a mutant cancer protein called HER2 (human epidermal growth factor receptor 2) without ...

Antibodies show promise as candidates for therapeutics as well as tools for advancing mechanistic studies of the HER family receptors.

Claudin 18.2 testing is a crucial step in determining whether Vyloy will be an effective treatment option for you patients ...

Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...

On October 8, 2024, The Office actor Jenna Fischer shared via an Instagram post that she was diagnosed with stage 1 ...

Drs Kathy Miller and Nancy U. Lin discuss central nervous system involvement in HER2 positive breast cancer, including the biology and management of patients.

A study published in Clinical Cancer Research confirmed that tissue stiffening in the most common types of breast cancer, HER2-negative, can directly cause disease progression and metastasis, leading ...

These breakthrough therapies have not only improved survival rates but also provided more targeted, less invasive options.

Because of technological advancements in healthcare, the market is expected to reach USD 1779.8 million by 2033.“Increased ...